Impact of diabetes on mortality after the first myocardial infarction

Diabetes Care

Volumn 21, Issue 1, 1998, Pages 69-75

  Miettinen, Heikki ^a,b   Lehto, Seppo ^b   Salomaa, Veikko ^c   Mähönen, Markku ^c   Niemelä, Matti ^d   Haffner, Steven M ^a   Pyörälä, Kalevi ^b   Tuomilehto, Jaakko ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Loimaa Regional Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; FINLAND; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY;

EID: 0037903801     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.1.69     Document Type: Article

References (43)

1. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3:463-524, 1987
2. Rytter L, Troelsen S, Beck-Nielsen H: Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 8:230-234, 1985
3. Czyzk A, Krolewski AS, Szablowska S, Alot A, Kopczynski J: Clinical course of myocardial infarction among diabetic patients. Diabetes Care 3:526-529, 1980
4. Martin CA, Thompson PL, Armstrong BK, Hobbs MST, De Klerk N: Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register. Circulation 68:961-969, 1983
5. Smith JW, Marcus Fi, Serokman R, with the Multicenter Postinfarction Research Group: Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 54:718-721, 1984
6. Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM: Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 62:665-669, 1988
7. Malmberg K, Ryden L: Myocardial infarction in patients with diabetes mellitus. Eur Heart J 9:259-264, 1988
8. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23:105-111, 1974
9. Cooper RS, Pacold IV, Ford ES: Age-related differences in case-fatality rates among diabetic patients with myocardial infarction: findings from National Hospital Discharge Survey, 1979-1987. Diabetes Care 14:903-908, 1991
10. Barbash GI, White HD, Modan M, Van de Werf F, for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol 22:707-713, 1993
11. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG: Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol 22:1788-1794, 1993
12. Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, Kereiakes DJ, Topol E, the TAMI Study Group: Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. J Am Coll Cardiol 21:920-925, 1993
13. Abbud ZA, Shindler DM, Wilson AC, Kostis JB: Effect of diabetes mellitus on short-and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J 130:51-58, 1995
14. Waller B, Palumbo P, Roberts W: Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Am J Med 69:498-506, 1980
15. Davies MJ, Bland JM, Hangartner JR, Angelini A, Thomas AC: Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J 10:203-208, 1989
16. Silva JA, Fscobar A, Collins TJ, Ramee SR, White CJ: Unstable angina: a comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation 92:1731-1736, 1995
17. Zarich SW, Nesto RW: Diabetic cardiomyopathy. Am Heart J 118:1100-1112, 1989
18. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T, Braunwald E, Jaffe AS, the MILIS Study Group: The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis: the MILIS Study Group. J Am Coll Cardiol 14:49-57, 1989
19. Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, Deychak Y, Simoons ML, Califf RM, Topol EJ, Ross AM, for the GUSTO-1 Angiographic Investigators: Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-1 experience. J Am Coll Cardiol 28:1661-1669, 1996
20. WHO MONICA Project Principal Investigators, prepared by Tunstall-Pedoe H: The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 41:105-114, 1988
21. WHO MONICA Project prepared by Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A-M, Pajak A: Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates and case fatality in 38 populations from 21 countries in four continents. Circulation 90:583-612, 1994
22. Tuomilehto J, Arstila M, Kaarsalo E, Kankaanpää J, Ketonen M, Kuulasmaa K, Lehto S, Miettinen H, Mustaniemi H, Palomäki P, Puska P, Pyörälä K, Salomaa V, Torppa J, Vuorenmaa T: Acute myocardial infarction (AMI) in Finland-baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J 13:577-587, 1992
23. Palomäki P, Miettinen H, Mustaniemi H, Lehto S, Pyörälä K, Mähönen M, Tuomilehto J: Diagnosis of acute myocardial infarction by MONICA and FINMONICA diagnostic criteria in comparison with hospital discharge diagnosis. J Clin Epidemiol 47:659-666, 1994
24. Mähönen M, Miettinen H, Pyörälä K, Molarius A, Salomaa V, Kuulasmaa K, for the FINMONICA AMI Register Study Team: Hospital discharge register data in the assessment of trends in acute myocardial infarction. Ann Med 27:547-554, 1995
25. Mähönen M: The reliability of hospital discharge data as a tool for epidemiologic research on ischaemic heart disease: comparison of the hospital discharge register and the FINMONICA AMI Register. Tutkimuksia (Research Reports), no. 28. Jyväskyä, Finland, STAKES (National Research and Development Center for Welfare and Health), 1993
26. SAS/Stat User's Guide: Statistics. Version 5. Vols. 1 and 2, 4th ed. Cary, NC, SAS Inst., 1990
27. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM, for the GUSTO-1 Investigators: Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from the international trial of 41 021 patients. Circulation 91:1659-1668, 1995
28. Abbott RD, Donahue RP, Kannel WB, Wilson PW: The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA 260:3456-3460, 1988
29. Barrett-Connor EL, Cohn B, Wingaard DL, Edelstein SL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 265:627-631, 1991
30. Rissanen V, Romo M, Siltanen P: Pre-hospital sudden death from ischaemic heart disease: a post-mortem study. Br Heart J 40:1025-1033, 1978
31. Davies MJ, Thomas A: Thrombosis and acute coronary artery lesions in sudden cardiac ischaemic death. N Engl J Med 310:1137-1140, 1984
32. Falk E: Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 71:699-708, 1985
33. Rehnberg S: Findings on Admission in Patients With Suspected Acute Myocardial Infarction in Relation to the Verified Diagnosis, Clinical Course and Short-Term and Long-Term Prognosis. Medicine, Original Studies, no. 15. Kuopio, Finland, University of Kuopio, 1989
34. Suhonen O: Sudden coronary death in middle age and characteristics of its victims in Finland. Acta Med Scand 214:207-214, 1983
35. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä 1: Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 11:449-463, 1988
36. Laakso M, Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K: Does NIDDM increase the risk for coronary heart disease similarly in both low-and high-risk populations? Diabetologia 38:487-493, 1995
37. Tuomilehto J, Korhonen HJ, Kartovaara L, Salomaa V, Stengard JH, Pitkanen M, Aro A, Javela K, Uusitupa M, Pitkaniemi J: Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 20:1010-1017, 1991
38. Malmberg K, Rydén L, Efendic S, Herliz J, Nicol P, Waldenström A, Wedel H, Welin L: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 26:57-66, 1995
39. Stamler J, Vaccaro O, Neaton JD, Wentworth D, the Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 15:820-825, 1993
40. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol: Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol (Adult Treatment Panel II). JAMA 209:3015-3023, 1993
41. Pyörälä K, De Backer G, Poole-Wilson P, Wood D, on behalf of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension: Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 15:1300-1331, 1994
42. Pyörälä K, Pedersen TR, Kjekshus J, Faergeman O, Olson AG, Thorgeirsson S, the Scandinavian Simvastatin Study (4S) Group: Cholesterol lowering with simvastatin improves prognosis in diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Study Group. Diabetes Care 20:614-620, 1997
43. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis BR, Braunwald E, the Cholesterol and Recurrent Events Trial Investigators: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001-1009, 1996